Immunovant COO’s Routine Sell‑to‑Cover Raises Eyebrows Amid Wave of Insider Selling and Investor Probe
Immunovant insider sell‑to‑cover by COO Gloria Melanie shows routine tax compliance amid broader executive trading; investors watch for future discretionary sales and potential market impact.
3 minutes to read